粉样性心肌病症中慢性无能症的患病率和功能影响:多中心分析
Damiano Magrì1,2, Nikita Ermolaev3, Robin Willixhofer3
1Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Heart (British Cardiac Society)
|January 11, 2025
概括
慢性无能症 (CI) 在粉状心肌病中很常见,并且与运动能力的降低有关. 75%或以下的峰值心率百分比 (pHR%) 可能会识别显著的运动障碍,即使没有心肺运动测试 (CPET).
科学领域:
- 心脏病学 心脏病学
- 运动生理学 运动生理学
背景情况:
- 有限的数据存在于运动期间的心率 (HR) 响应及其与粉样性心肌病症功能能力的联系.
- 粉样性心肌病可以影响心脏功能和运动耐受性.
研究的目的:
- 为了确定患有粉样性心肌病的患者慢性无能症 (CI) 的患病率.
- 为了研究CI和心肺运动测试 (CPET) 变量之间的关系.
主要方法:
- 分析了172名患有粉状心肌病的门诊患者的数据,这些患者接受了最大CPET.
- 排除具有显著节律障碍的患者.
主要成果:
- 根据使用的年龄预测峰值HR (pHR%) 截止值,CI的患病率从16%到59%不等.
- pHR%与氧气吸收峰值 (pVO2) 有非线性相关性,与通风效率有反向相关性.
- 一个pHR%的切线≤75%准确地确定了中度至重度的运动障碍 (72%的灵敏度,73%的特异性).
结论:
- 脉节律中amyloid心肌病患者的CI普遍存在,其患病率取决于pHR%的切断值.
- 在这个人群中,运动诱导的HR反应与运动能力差相关.
- pHR% ≤75%可能有助于在缺乏CPET的环境中识别显著的运动障碍.
关键词:
心肌病,限制性心肌病更多相关视频
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
2.9K
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
2.0K
相关概念视频
Mechanism of Cardiac Arrhythmias
886
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
886
Pathophysiology of Cardiac Performance
530
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
530
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents
515
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
